Clinical Trials Browser

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Fallopian Tube Neoplasms, Mesothelioma, Ovarian Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT06166836 2026-03-03

a Study to Evaluate the Safety and Efficacy of D-1553 Combined With IN10018 in KRAS G12C Mutant Solid Tumors

Phase 1/2 Recruiting

140 enrolled

Other solid neoplasm

Solid Tumor

NCT06685068 2026-03-03

A Phase 1/2 Study of GEN1286 in Patients With Advanced Solid Tumors

Phase 1/2 Active not recruiting

23 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT07446855 2026-03-03

PARTHENON

Phase 1/2 Not yet recruiting

180 enrolled

Other solid neoplasm

Solid Tumours

NCT05083481 2026-02-27

A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors

Phase 1/2 Recruiting

366 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT06833008 2026-02-27

A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours

Phase 1/2 Recruiting

85 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT07436728 2026-02-27

A Study of TAK-505 in Adults With Solid Tumors

Phase 1/2 Not yet recruiting

151 enrolled

Other solid neoplasm

Malignant Solid Tumors

NCT07441174 2026-02-27

IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid Tumors

Phase 1/2 Recruiting

92 enrolled

GastrointestinalOther solid neoplasm

Solid Tumor Cancer

NCT04219254 2026-02-25

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Phase 1/2 Recruiting

197 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT06911827 2026-02-25

A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients

Phase 1/2 Recruiting

90 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT06051695 2026-02-20

EVEREST-2

Phase 1/2 Recruiting

474 enrolled

GastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Mesothelioma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Colorectal Neoplasms

NCT07160725 2026-02-17

A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors

Phase 1/2 Recruiting

315 enrolled

Other solid neoplasm

Solid Tumours

NCT07293754 2026-02-17

RaPTR-101

Phase 1/2 Recruiting

150 enrolled

Other solid neoplasm

Advanced Malignant Solid Tumor

NCT07415863 2026-02-17

Phase 1/II Clinical Study of SYS6043 in the Treatment of Advanced/Metastatic Solid Tumors

Phase 1/2 Recruiting

820 enrolled

Other solid neoplasm

Advanced/Metastatic Solid Tumors

NCT06885281 2026-02-13

A Study of ZL-1310 in Participants With Selected Solid Tumors

Phase 1/2 Recruiting

112 enrolled

Other solid neoplasm

Solid Tumors

NCT03917381 2026-02-11

GEN1046 Safety Trial in Patients With Malignant Solid Tumors

Phase 1/2 Active not recruiting

429 enrolled

Other solid neoplasm

Solid Tumors

NCT07328217 2026-02-11

A Phase 1/2 Study of GW5282 in Participants With Advanced Solid Tumors

Phase 1/2 Recruiting

203 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT07396584 2026-02-09

A Phase I/Ⅱa Study of HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor

Phase 1/2 Not yet recruiting

186 enrolled

Other solid neoplasm

Solid Tumors, Adult

NCT07205718 2026-02-06

A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors

Phase 1/2 Recruiting

223 enrolled

Other solid neoplasm

Advanced or Metastatic Solid Tumors

NCT07392736 2026-02-06

A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors.

Phase 1/2 Recruiting

228 enrolled

Other solid neoplasm

Solid Tumor

NCT07359066 2026-02-05

An Open-label, First-in-Human, Dose-Escalation and Dose-Expansion Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPR1020 in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

210 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05518045 2026-02-04

A Study of LM-108 as Monotherapy or in Combination With Antitumor Therapies in Subjects With Advanced Solid Tumors

Phase 1/2 Active not recruiting

392 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT07382531 2026-02-04

OH2 Injection in Combination With BS006 Injection for Advanced Solid Tumors

Phase 1/2 Recruiting

30 enrolled

Other solid neoplasm

Solid Tumor

NCT05443126 2026-02-03

A Study of EP0031 in Patients With Advanced RET-altered Malignancies

Phase 1/2 Recruiting

265 enrolled

Other solid neoplasmThoracic

Advanced Solid Tumor

NCT05756907 2026-02-03

Combination of SON-1010 (IL12-FHAB) and Atezolizumab in Patients With Platinum-resistant Ovarian Cancer

Phase 1/2 Terminated

40 enrolled

GynecologicOther solid neoplasm

Advanced Solid Tumor

Clinical Trials

First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors

Study in Advanced Solid Tumor Patients

aCCeleR8-001

Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors

A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)

SNV4818 in Participants With Advanced Solid Tumors

BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

A Study YL201 in Patients With Selected Advanced Solid Tumors

A IB/II Phase Clinical Study on the Safety, Tolerability, and Efficacy of SHR-9839(sc) in Combination Anti-tumor Therapy in Patients With Solid Tumors

A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors

LuMIERE

A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors

A Phase I/II Study of ABSK141 in Patients With Advanced Solid Tumors ( ABSK141-101 )

A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid Tumors

SKB103 for Injection in Advanced Solid Tumors

A Study to Evaluate Claudin 18.2-Directed ADC LCB02A in Advanced Solid Tumors

A Phase I/Ⅱ Human Study of HY0001a for Injection in Adult Participants With Advanced Solid Tumors

Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors

PRIMROSE

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors

Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors

A Phase Ib/II Clinical Study of AK127 in Combination With AK112 in Patients With Advanced Solid Tumors

Study of JK06 in Patients With Unresectable Locally Advanced or Metastatic Cancer

MARGARET

RAINFOL-01

a Study to Evaluate the Safety and Efficacy of D-1553 Combined With IN10018 in KRAS G12C Mutant Solid Tumors

A Phase 1/2 Study of GEN1286 in Patients With Advanced Solid Tumors

PARTHENON

A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors

A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours

A Study of TAK-505 in Adults With Solid Tumors

IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid Tumors

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients

EVEREST-2

A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors

RaPTR-101

Phase 1/II Clinical Study of SYS6043 in the Treatment of Advanced/Metastatic Solid Tumors

A Study of ZL-1310 in Participants With Selected Solid Tumors

GEN1046 Safety Trial in Patients With Malignant Solid Tumors

A Phase 1/2 Study of GW5282 in Participants With Advanced Solid Tumors

A Phase I/Ⅱa Study of HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor

A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors

A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors.

An Open-label, First-in-Human, Dose-Escalation and Dose-Expansion Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPR1020 in Patients With Advanced Solid Tumors

A Study of LM-108 as Monotherapy or in Combination With Antitumor Therapies in Subjects With Advanced Solid Tumors

OH2 Injection in Combination With BS006 Injection for Advanced Solid Tumors

A Study of EP0031 in Patients With Advanced RET-altered Malignancies

Combination of SON-1010 (IL12-FHAB) and Atezolizumab in Patients With Platinum-resistant Ovarian Cancer